Targeting cellular DNA damage responses in cancer: An in vitro -calibrated agent-based model simulating monolayer and spheroid treatment responses to ATR-inhibiting drugs (2019)
Attributed to:
Developing new paradigms for overcoming drug resistance in cancer using novel humanised mouse models
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/841270
Publication URI: http://dx.doi.org/10.1101/841270
Type: Preprint